Acupuncture for irritable bowel syndrome: Systematic review and meta-analysis

American Journal of Gastroenterology

Volumn 107, Issue 6, 2012, Pages 835-847

  Manheimer, Eric ^a   Wieland, L Susan ^a   Cheng, Ke ^b   Li, Shih Min ^c   Shen, Xueyong ^b   Berman, Brian M ^a   Lao, Lixing ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HERBACEOUS AGENT; LOPERAMIDE; MONTMORILLONITE; PINAVERIUM BROMIDE; PLACEBO; PROBIOTIC AGENT; SALAZOSULFAPYRIDINE; TRIMEBUTINE MALEATE;

ACUPUNCTURE; BIFIDOBACTERIUM LONGUM; CHINESE MEDICINE; CINAHL; COCHRANE LIBRARY; COMPARATIVE EFFECTIVENESS; DISEASE SEVERITY; ELECTROACUPUNCTURE; EMBASE; ENTEROCOCCUS FAECIUM; HUMAN; IRRITABLE COLON; LACTOBACILLUS; MASSAGE; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; PSYCHOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SYNCOPE; SYSTEMATIC REVIEW;

ACUPUNCTURE THERAPY; EVIDENCE-BASED MEDICINE; GASTROINTESTINAL AGENTS; HUMANS; IRRITABLE BOWEL SYNDROME; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84861874440     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2012.66     Document Type: Review

References (77)

1. Brandt LJ, Chey WD, Foxx-Orenstein AE et al. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009;104 (Suppl 1):S1-35.
2. Saito YA, Schoenfeld P, Locke GR III. The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol 2002;97:1910-5.
3. Vanner SJ, Depew WT, Paterson WG et al. Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome. Am J Gastroenterol 1999;94:2912-7. (Pubitemid 29482757)
4. Saito YA, Locke GR, Talley NJ et al. A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol 2000;95:2816-24.
5. El-Serag HB, Olden K, Bjorkman D. Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther 2002;16:1171-85. (Pubitemid 34680762)
6. Maxion-Bergemann S, Thielecke F, Abel F et al. Costs of irritable bowel syndrome in the UK and US. Pharmacoeconomics 2006;24:21-37. (Pubitemid 43197228)
7. Longstreth GF, Wilson A, Knight K et al. Irritable bowel syndrome, health care use, and costs: a US managed care perspective. Am J Gastroenterol 2003;98:600-7. (Pubitemid 36348532)
8. Talley NJ, Gabriel SE, Harmsen WS et al. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology 1995;109:1736-41.
9. Everhart JE. The Burden of Digestive Diseases in the United States. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. US Government Printing Office: Washington, DC, 2008, pp 142 NIH Publication No. 09-6443.
10. Ford AC, Talley NJ, Schoenfeld PS et al. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut 2009;58:367-78.
11. Brenner DM, Moeller MJ, Chey WD et al. The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review. Am J Gastroenterol 2009;104:1033-49;Quiz 1050.
12. Manheimer E, Wieland LS, Cheng K et al. Acupuncture for treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2012;(5):CD005111.
13. Macpherson H, Thomas K, Walters S et al. The York acupuncture safety study: prospective survey of 34 000 treatments by traditional acupuncturists. BMJ 2001;323:486-7. (Pubitemid 32822288)
14. Melchart D, Weidenhammer W, Streng A et al. Prospective investigation of adverse effects of acupuncture in 97 733 patients. Arch Intern Med 2004;164:104-5. (Pubitemid 38067398)
15. White A, Hayhoe S, Hart A et al. Adverse events following acupuncture: prospective survey of 32 000 consultations with doctors and physiotherapists. BMJ 2001;323:485-6. (Pubitemid 32822287)
16. Ford AC, Guyatt GH, Talley NJ et al. Errors in the conduct of systematic reviews of pharmacological interventions for irritable bowel syndrome. Am J Gastroenterol 2010;105:280-8.
17. Wu T, Li Y, Bian Z et al. Randomized trials published in some Chinese journals: how many are randomized? Trials 2009;10:46.
18. Ezzo JM, Richardson MA, Vickers A et al. Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting. Cochrane Database Syst Rev 2006:(2):CD002285.
19. Mangel AW, Hahn BA, Heath AT et al. Adequate relief as an endpoint in clinical trials in irritable bowel syndrome. J Int Med Res 1998;26:76-81. (Pubitemid 28211930)
20. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997;11:395-402. (Pubitemid 27183522)
21. Patrick DL, Drossman DA, Frederick IO et al. Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci 1998;43:400-11. (Pubitemid 28124621)
22. Bijkerk CJ, De Wit NJ, Muris JW et al. Outcome measures in irritable bowel syndrome: comparison of psychometric and methodological characteristics. Am J Gastroenterol 2003;98:122-7. (Pubitemid 36135180)
23. Irvine EJ, Whitehead WE, Chey WD et al. Design of treatment trials for functional gastrointestinal disorders. Gastroenterology 2006;130:1538-51.
24. Ford AC, Brandt LJ, Young C et al. Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol 2009;104:1831-43;Quiz 1844.
25. Furlan AD, van Tulder MW, Cherkin DC et al. Acupuncture and dry-needling for low back pain. Cochrane Database Syst Rev 2005:(1):CD001351.
26. Manheimer E, Cheng K, Linde K et al. Acupuncture for peripheral joint osteoarthritis. Cochrane Database Syst Rev 2010:(1):CD001977.
27. Manheimer E, Linde K, Lao L et al. Meta-analysis: acupuncture for osteoarthritis of the knee. Ann Intern Med 2007;146:868-77. (Pubitemid 351650487)
28. Higgins JPT, Altman DG (eds). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 [Updated March 2011]. The Cochrane Collaboration, 2011 Available From www.Cochrane-Handbook.Org (Accessed 5 October 2011).
29. Streitberger K, Kleinhenz J. Introducing a placebo needle into acupuncture research. Lancet 1998;352:364-5. (Pubitemid 28352200)
30. Review Manager (RevMan) [Computer Program] Version 5.1. The Nordic Cochrane Centre, The Cochrane Collaboration: Copenhagen, 2011.
31. Higgins JP, Thompson SG, Deeks JJ et al. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60. (Pubitemid 37088507)
32. Deeks JJ, Higgins JPT, Altman DG (eds). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 [Updated March 2011]. The Cochrane Collaboration, 2011 Available From www.Cochrane-Handbook.Org (Accessed 5 October 2011).
33. An G, Li N, Zhai G et al. Evaluation of the therapeutic effect of acupuncture and moxibustion on irritable bowel syndrome]. Shanghai J Acu-mox 2010;29:354-6.
34. Anastasi JK, Mcmahon DJ, Kim GH. Symptom management for irritable bowel syndrome: a pilot randomized controlled trial of acupuncture/moxibustion. Gastroenterol Nurs 2009;32:243-55.
35. Chen Q. Clinical Study on Irritable Bowel Syndrome of Diarrhea Type with Chang-Three-Needle Technique. Guangzhou University Of Traditional Chinese Medicine Master's Thesis: Guangzhou, 2011.
36. Chen Y, Lai X. Clinical observation on combined warming needle and patented Chinese medicine for irritable bowel syndrome. J Acupunct Tuina Sci 2009;7:274-7.
37. Forbes A, Jackson S, Walter C et al. Acupuncture for irritable bowel syndrome: a blinded placebo-controlled trial. World J Gastroenterol 2005;11:4040-4. (Pubitemid 41235601)
38. Lembo AJ, Conboy L, Kelley JM et al. A treatment trial of acupuncture in IBS patients. Am J Gastroenterol 2009;104:1489-97.
39. Li W. Treatment of warming needle moxibustion combined with spinal manipulation on irritable bowel syndrome. China Pract Med 2009;4:212-3.
40. Liu GZ. Treatment of acupuncture and moxibustion plus psychotherapy for irritable bowel syndrome. Chinese Acupunct Moxibust 1997;10:611-2.
41. Liu Q, Wang Z, Zhang W et al. Clinical observation on geshanxiaoyao decoction combining acupuncture effect on the life quality of patients with irritable bowel syndrome. Journal Of Zhejiang Chinese Medical University 2010;34:510-3.
42. Lowe C, Depew W, Vanner S. A placebo-controlled, double-blind trial of acupuncture in the treatment of irritable bowel syndrome (IBS). Gastroenterology 2000;118:A3168.
43. Reynolds JA, Bland JM, Macpherson H. Acupuncture for irritable bowel syndrome an exploratory randomised controlled trial. Acupunct Med 2008;26:8-16. (Pubitemid 351482224)
44. Schneider A, Enck P, Streitberger K et al. Acupuncture treatment in irritable bowel syndrome. Gut 2006;55:649-54.
45. Shi X, Luo J, Tan T. Clinical observation of electroacupuncture on diarrhea-predominant irritable bowel syndrome. J New Chinese Med 2010;42:72-4.
46. Sun JH, Wu XL, Xia C et al. Clinical evaluation of soothing gan and invigorating pi acupuncture treatment on diarrhea-predominant irritable bowel syndrome. Chin J Integr Med 2011;17:780-5.
47. Xiong X, Lin Y. Acupuncture plus traditional Chinese herb medicine in treating 42 patients with diarrhea-predominant IBS. Journal of Fujian University of TCM 2008;18:38-40.
48. Xue Y, Tian X. The clinical research of the relationship between radicals and irritable bowel syndrome and the effect of acupuncture ]. Chinese Archives of Traditional Chinese Medicine 2009;27:111-2.
49. Zeng Y, Bao Y, Chu J et al. Effect of moxibustion for diarrhea-dominant irritable bowel syndrome patients in dog days]. Chinese Archives of Traditional Chinese Medicine 2010;28:1774-6.
50. Fireman Z, Segal A, Kopelman Y et al. Acupuncture treatment for irritable bowel syndrome. a double-blind controlled study. Digestion 2001;64:100-3.
51. Liao YC. Acupuncture treatment for 132 cases of irritable bowel syndrome]. Clin J Acupunct Moxibust 2000;16:13-4.
52. Liu M. Clinical report of ear acupuncture treatment for functional gastric disorder]. Shanghai J Acupunct Moxibust 1995;14:247-8.
53. Ruepert L, Quartero AO, De Wit NJ et al. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2011:(8):CD003460.
54. Flum DR. Interpreting surgical trials with subjective outcomes: avoiding unsportsmanlike conduct. JAMA 2006;296:2483-5. (Pubitemid 44791206)
55. O ' Connell NE, Wand BM, Goldacre B. Interpretive bias in acupuncture research?: A case study. Eval Health Prof 2009;32:393-409.
56. Kaptchuk TJ, Stason WB, Davis RB et al. Sham device v inert pill: randomised controlled trial of two placebo treatments. BMJ 2006;332:391-7.
57. Linde K, Witt CM, Streng A et al. The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain. Pain 2007;128:264-71. (Pubitemid 46367430)
58. Wechsler ME, Kelley JM, Boyd IO et al. Active albuterol or placebo, sham acupuncture, or no intervention in asthma. N Engl J Med 2011;365:119-26.
59. Spiller RC. Problems and challenges in the design of irritable bowel syndrome clinical trials: experience from published trials. Am J Med 1999;107:91s-7s.
60. Ezzo J, Lao L, Berman B. Assessing clinical efficacy of acupuncture: what has been learned from systematic reviews of acupuncture?. In: Stux G, Hammerschlag R (eds). Clinical Acupuncture: Scientific Basis. Springer: New York, 2001, pp 113-30.
61. Schulz KF, Grimes DA. Unequal group sizes in randomised trials: guarding against guessing. Lancet 2002;359:966-70. (Pubitemid 34246392)
62. Adetugbo K, Williams H. How well are randomized controlled trials reported in the dermatology literature? Arch Dermatol 2000;136:381-5. (Pubitemid 30149113)
63. Jailwala J, Imperiale TF, Kroenke K. Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials. Ann Intern Med 2000;133:136-47. (Pubitemid 30490414)
64. Pasricha PJ. Desperately seeking serotonin. A commentary on the withdrawal of tegaserod and the state of drug development for functional and motility disorders. Gastroenterology 2007;132:2287-90. (Pubitemid 46890891)
65. Thompson CA. Alosetron withdrawn from market. Am J Health Syst Pharm 2001;58:13.
66. Gaylord SA, Palsson OS, Garland EL et al. Mindfulness training reduces the severity of irritable bowel syndrome in women: results of a randomized controlled trial. Am J Gastroenterol 2011;106:1678-88.
67. Lindfors P, Unge P, Arvidsson P et al. Effects of gut-directed hypnotherapy on IBS in different clinical settings-results from two randomized, controlled trials. Am J Gastroenterol 2012;107:276-85.
68. Kalauokalani D, Cherkin DC, Sherman KJ et al. Lessons from a trial of acupuncture and massage for low back pain: patient expectations and treatment effects. Spine (Phila Pa) 1976)) ; 2001:1418-24.
69. Macpherson H, Bland M, Bloor K et al. Acupuncture for irritable bowel syndrome: a protocol for a pragmatic randomised controlled trial. BMC Gastroenterol 2010;10:63.
70. Hrobjartsson A, Gotzsche PC. Placebo interventions for all clinical conditions. Cochrane Database Syst Rev 2004:(3):CD003974.
71. Wood L, Egger M, Gluud LL et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 2008;336:601-5. (Pubitemid 351439518)
72. Manheimer E. Selecting a control for in vitro fertilization and acupuncture randomized controlled trials (RCTs): how sham controls may unnecessarily complicate the RCT evidence base. Fertil Steril 2011;95:2456-61.
73. Whitehead WE, Corazziari E, Prizont R et al. Definition of a responder in clinical trials for functional gastrointestinal disorders: report on a symposium. Gut 1999;45 Suppl 2:II78-9. (Pubitemid 29434817)
74. Johnson JA, Coons SJ. Comparison of the EQ-5d and SF-12 in an adult US sample. Qual Life Res 1998;7:155-66. (Pubitemid 28097903)
75. Groll D, Vanner SJ, Depew WT et al. The IBS-36: a new quality of life measure for irritable bowel syndrome. Am J Gastroenterol 2002;97:962-71. (Pubitemid 34408255)
76. Chassany O, Marquis P, Scherrer B et al. Validation of a specific quality of life questionnaire for functional digestive disorders. Gut 1999;44:527-33. (Pubitemid 29169953)
77. Heaton KW, Ghosh S, Braddon FE. How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form. Gut 1991;32:73-9.